FR2052969B1 - - Google Patents

Info

Publication number
FR2052969B1
FR2052969B1 FR7021789A FR7021789A FR2052969B1 FR 2052969 B1 FR2052969 B1 FR 2052969B1 FR 7021789 A FR7021789 A FR 7021789A FR 7021789 A FR7021789 A FR 7021789A FR 2052969 B1 FR2052969 B1 FR 2052969B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7021789A
Other languages
French (fr)
Other versions
FR2052969A1 (fi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Draco AB
Original Assignee
Draco AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco AB filed Critical Draco AB
Publication of FR2052969A1 publication Critical patent/FR2052969A1/fr
Application granted granted Critical
Publication of FR2052969B1 publication Critical patent/FR2052969B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
FR7021789A 1969-06-13 1970-06-12 Expired FR2052969B1 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE841269A SE354279B (fi) 1969-06-13 1969-06-13

Publications (2)

Publication Number Publication Date
FR2052969A1 FR2052969A1 (fi) 1971-04-16
FR2052969B1 true FR2052969B1 (fi) 1974-05-24

Family

ID=20274010

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7021789A Expired FR2052969B1 (fi) 1969-06-13 1970-06-12

Country Status (13)

Country Link
JP (1) JPS541304B1 (fi)
BE (1) BE751792A (fi)
CA (1) CA959497A (fi)
CH (1) CH551373A (fi)
DE (1) DE2029000A1 (fi)
DK (1) DK129992B (fi)
FI (1) FI55648C (fi)
FR (1) FR2052969B1 (fi)
GB (1) GB1283632A (fi)
IE (1) IE34590B1 (fi)
NL (1) NL7008654A (fi)
NO (1) NO129950B (fi)
SE (1) SE354279B (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2401450A1 (de) * 1973-01-16 1974-07-18 John James Voorhees Pharmazeutische zusammensetzung zur linderung von hautproliferationserkrankungen
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
EP2064174B1 (en) 2006-08-10 2016-10-26 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Preparation of (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
AU2013202127B2 (en) * 2006-08-10 2014-06-12 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (R,R-)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
AU2011224241B2 (en) 2010-03-10 2014-05-08 Sri International The use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

Also Published As

Publication number Publication date
DK129992B (da) 1974-12-09
NL7008654A (fi) 1970-12-15
DK129992C (fi) 1975-06-16
IE34590L (en) 1970-12-13
GB1283632A (en) 1972-08-02
SE354279B (fi) 1973-03-05
IE34590B1 (en) 1975-06-25
FR2052969A1 (fi) 1971-04-16
BE751792A (fr) 1970-11-16
CA959497A (en) 1974-12-17
FI55648B (fi) 1979-05-31
JPS541304B1 (fi) 1979-01-23
NO129950B (fi) 1974-06-17
FI55648C (fi) 1979-09-10
CH551373A (de) 1974-07-15
DE2029000A1 (fi) 1970-12-23

Similar Documents

Publication Publication Date Title
AU2270770A (fi)
AU465452B2 (fi)
AU429630B2 (fi)
AU450150B2 (fi)
AU2355770A (fi)
AU442375B2 (fi)
AU427401B2 (fi)
AU470301B1 (fi)
AU442380B2 (fi)
AU410358B2 (fi)
AU428074B2 (fi)
AU428129B2 (fi)
AU428131B2 (fi)
AU417208B2 (fi)
AU442463B2 (fi)
AU438128B2 (fi)
AU470661B1 (fi)
AU442285B2 (fi)
AU442322B2 (fi)
AU442357B2 (fi)
AU414607B2 (fi)
AU425297B2 (fi)
AU442554B2 (fi)
AU442535B2 (fi)
AU442538B2 (fi)

Legal Events

Date Code Title Description
ST Notification of lapse